wire - news in brief




Page not found (Error 404)





Category



Results 351 - 385 of 385.


Business / Economics - Innovation - 06.06.2019

Life Sciences - Health - 06.06.2019
How flow shapes bacterial biofilms
How flow shapes bacterial biofilms
EPFL biophysicists have taken a systematic look into how bacterial biofilms are affected by fluid flow. The findings can give us clues about the physical rules guiding biofilm architecture, but also about the social dynamics that shape evolution. Although we tend to think of them as solitary sojourners of the world, bacteria are actually very social organisms.

Environment - 06.06.2019
Four scientific institutions will monitor Switzerland from space
Four scientific institutions will monitor Switzerland from space
UNEP/GRID-Geneva, the universities of Geneva and Zurich and the Swiss Federal Institute for Forest, Snow and Landscape Research join forces for the continuous monitoring of Switzerland from space using the Swiss Data Cube.

Health - Pharmacology - 04.06.2019
Long-term survival benefit shown for metastatic melanoma patients treated with Novartis Tafinlar + Mekinist
Five-year Tafinlar + Mekinist survival data presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting and published simultaneously in The New England Journal of Medicine   Results are from the largest dataset and longest follow-up of more than 500 patients with BRAF-mutated metastatic melanoma, a genetic mutation common for this aggressive skin cancer   Additional Novartis melanoma research presented at ASCO includes effi

Pharmacology - Health - 04.06.2019
Pivotal phase III CLL14 results for Venclexta/Venclyxto in combination with Gazyva/Gazyvaro for chronic lymphocytic leukaemia presented at ASCO 2019 and published in the New England Journal of Medicine
Venclexta/Venclyxto plus Gazyva/Gazyvaro showed improvements across multiple efficacy measures compared to Gazyva/Gazyvaro plus chlorambucil, including progression-free survival and deep remissions a

Computer Science / Telecom - Mathematics - 04.06.2019
EPFL hosts first Swiss edition of youth cryptography competition
EPFL hosts first Swiss edition of youth cryptography competition
On May 28, the EPFL School of Computer and Communication Sciences (IC) and Science Outreach Department (SPS) organized the final of the first Swiss edition of the Alkindi Competition, where more than 40 secondary school students from across the country put their code-cracking skills to the test.

Pedagogy - 04.06.2019
Physical inactivity proved risky for children and pre-teens
Physical inactivity proved risky for children and pre-teens
Researchers from UNIGE have shown that children lose their motivation to participate in physical activities in PE classes at school from the age of nine.

Innovation - Administration - 03.06.2019

Life Sciences - 03.06.2019
Fathers Aid Development of Larger Brains
Fathers Aid Development of Larger Brains
The bigger the brain, the more intelligent a mammalian species is. Developing a large brain, though, requires a huge energy input.

Pharmacology - Health - 03.06.2019
Roche presents data from across its breast cancer portfolio at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
Roche data from 17 breast cancer abstracts presented at this year's meeting An overall survival improvement was observed with Tecentriq and nab-paclitaxel in PD-L1-positive metastatic triple-negative

Pharmacology - Health - 03.06.2019
Xolair (omalizumab) significantly reduced nasal polyps and congestion symptoms in adults with chronic rhinosinusitis with nasal polyps in two phase III studies
In the phase III POLYP 1 and POLYP 2 studies, omalizumab met both co-primary endpoints and key secondary endpoints in adults with chronic rhinosinusitis with nasal polyps (CRSwNP) with inadequate res

Pharmacology - Health - 03.06.2019
Novartis Shows Growing Strength in Lung Cancer Innovation with New Capmatinib Investigational Data and Novel Canakinumab Clinical Trials
Primary analysis of investigational capmatinib (INC280) in the GEOMETRY mono-1 study demonstrates promising efficacy in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)

Pharmacology - Health - 02.06.2019
Roche’s Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer shows positive data in those with liver metastases
Data will be presented at the American Society of Clinical Oncology (ASCO) annual meeting on 2 June 2019 Roche today announced positive additional results of a prespecified exploratory analysis from

Health - Pharmacology - 01.06.2019
Novartis Kisqali significantly extends life in women with HR+/HER2- advanced breast cancer in MONALEESA-7 trial
Kisqali is the only CDK4/6 inhibitor to show superior overall survival in advanced breast cancer (HR=0.712; p=0.00973) After a median of 42 months follow-up, the survival rate was 70&pe

Innovation - 31.05.2019
Desalinating water in a greener and more economical way
Desalinating water in a greener and more economical way
Researchers at EPFL have developed a machine that turns seawater into drinking water in a more environmentally friendly and economical way than existing systems.

Health - Business / Economics - 31.05.2019
Roche and GE Healthcare launch NAVIFY Tumor Board with medical imaging capabilities to enable more personalised treatment decisions in cancer care
Radiologists can now upload their patient records to the same dashboard as patient files from other disciplines First collaboration product enables tumour boards to have a more comprehensive view of

Pharmacology - Health - 30.05.2019
Novartis’ phase III QUARTZ study of new investigational inhaled combination treatment QMF149 meets primary and key secondary endpoints in patients with inadequately controlled asthma
Low dose QMF149 (indacaterol acetate and mometasone furoate) demonstrated both statistically significant and clinically meaningful improvements in lung function and asthma control compared to inhaled

Environment - Health - 30.05.2019
European Scientists Call for Climate Action
European Scientists Call for Climate Action
A new report highlights an alarming range of health risks in Europe due to climate change and the benefits of a rapid phase out of fossil fuels. The report entitled "The imperative of climate action to protect human health in Europe" was published yesterday by the European Academies' Science Advisory Council (EASAC).

Mechanical Engineering - 29.05.2019

Politics - Astronomy / Space Science - 28.05.2019
ESA and EU member states highlight the importance of the space sector
The State Secretary for Education, Research and Innovation, Martina Hirayama, participated to the 'Space Council' of ESA and EU member states in Brussels today.

Innovation - Environment - 27.05.2019
ReMaP - Key to the energy systems of the future
Our energy system is changing: The permanent availability of energy in the right place at the right time is becoming more demanding. At the same time, digitalization offers us new tools for better controlling energy flows. A new joint energy research platform of ETH Zurich, the Paul Scherrer Institute (PSI) and Empa - ReMaP - aims at contributing to a better understanding of interconnected future energy systems.

Astronomy / Space Science - 27.05.2019
Getting to Mars, whatever it takes
Getting to Mars, whatever it takes
Sending manned missions to Mars is essential, according to Pierre Brisson, the president of Mars Society Switzerland, "because we can." We spoke with him about this challenge while he was at EPFL recently to give a talk.  Pierre Brisson, a planetology enthusiast who heads the Swiss chapter of the Mars Society, believes in the need to send people to Mars.

Health - Pharmacology - 24.05.2019
FDA approves Novartis Piqray - the first and only treatment specifically for patients with a PIK3CA mutation in HR+/HER2- advanced breast cancer
Piqray (alpelisib, formerly BYL719) plus fulvestrant nearly doubled median PFS (11.0 vs 5.7 months) in HR+/HER2- advanced breast cancer patients with a PIK3CA mutation compared to fulve

Health - Pharmacology - 24.05.2019
AveXis Announces Innovative Zolgensma Gene Therapy Access Programs for US Payers and Families
One-time treatment with Zolgensma (onasemnogene abeparvovec-xioi) is designed to replace lifetime of chronic therapy for all pediatric patients with SMA   Annualized cost of Zolgensma is USD 425,000

Health - Pharmacology - 24.05.2019
AveXis receives FDA approval for Zolgensma , the first and only gene therapy for pediatric patients with spinal muscular atrophy (SMA)
SMA is a rare genetic disease that leads to progressive muscle weakness, paralysis and, when left untreated in its most severe form, permanent ventilation or death for most patients by age 2 ,   Zolg

Environment - 24.05.2019
Website provides real-time forecasts for Swiss lakes
Website provides real-time forecasts for Swiss lakes
A new website, www.meteolakes.ch , provides up-to-date information - such as water temperature, current speed, the chances of a storm and the presence of algae and whirlpools - on Switzerland's main lakes.

Health - Pharmacology - 24.05.2019

Earth Sciences - Environment - 24.05.2019